Dr. Vincent Pellegrini discusses the PEPPER trial and the impact it could have on patient prophylaxis.
Originally filmed for NATF’s online support group.
Related Articles
April 7, 2020
The Science Behind Food: Diet for Cardiovascular Risk Reduction
In this episode of Patient Pulse, Dr. Michelle O’Donoghue from Brigham and Women’s Hospital focuses on a common patient question:…
April 1, 2020
Trial Tidbits: A Clinician’s Guide to ACC 2020
The 2020 American College of Cardiology, together with the World Congress of Cardiology, hosted the first-ever virtual Scientific Sessions from…
April 1, 2020
Clot Chronicles: Putting a Finger on Raynaud’s
Hi, I’m Dr. Marie Gerhard. I’m a vascular medicine doctor in the cardiovascular division of Brigham and Women’s Hospital, and…